Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism

NCT00465751 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Familial Hypertriglyceridemia
Familial Combined Hyperlipidemia

Interventions

DRUG: chenodeoxycholic acid
DRUG: placebo capsules

Sponsor

University Hospital, Basel, Switzerland